AUSTRALIAN AI BREAKS INTO THE NORTH AMERICAN MARKET

AUSTRALIAN AI BREAKS INTO THE NORTH AMERICAN MARKET
CRE8TEK (ASX: CR8), owner of Artificial Intelligence Company Flamingo Customer Experience Inc. (Flamingo), has announced its successful expansion into the American market.

The company's Flamingo program is being implemented by Nationwide, a Fortune 100 insurance company.

Flamingo's 'ROSIE' program, a virtual sales assistant, will be integrated into Nationwide's systems and will be used for online sales and post-sale customer service.

The complexity of the program and how it is integrated will take time, according to the company.

Flamingo was founded by Catriona Wallace who is also the Cre8tek CEO.

In Australia, AMP Limited is undertaking a paid trial of the Flamingo system, integrating the JourneyAssist platform and deploying the development and training of ROSIE.

DirectMoney will also undertake a paid trail of the Flamingo platform this is expected to run for six months and will focus on online sales of personal loan products.

CRE8TEK has also announced that Flamingo is one of eight finalists in MetLife Asia's Start-up accelerator program.

If successful, Flamingo will be awarded a US$100,000 to assist the company pilot the program with MetLife Asia in the Asian market.

Flamingo entered the ASX through a backdoor listing in November 2016. Cre8Tek also owns Global Agenda Technologies.

CR8 shares were up by just over 8 per cent to $0.039 at around 3pm AEST.

Business News Australia

Help us deliver quality journalism to you.
As a free and independent news site providing daily updates
during a period of unprecedented challenges for businesses everywhere
we call on your support

Advertisement

Related Stories

Hearing tech Audeara rises from fledgling startup to $21m ASX listing in six years

Hearing tech Audeara rises from fledgling startup to $21m ASX listing in six years

Six years ago, Audeara (ASX: AUA) was a start-up aiming to make h...

Australia orders 25 million COVID-19 vaccine doses from Moderna

Australia orders 25 million COVID-19 vaccine doses from Moderna

Biotechnology company Moderna (Nasdaq: MRNA) has entered into a n...

The pressure is on for Australia to accept the coronavirus really can spread in the air we breathe

The pressure is on for Australia to accept the coronavirus really can spread in the air we breathe

More than a year into the pandemic, the World Health Organization...

Qantas delays planned resumption of international flights to late December

Qantas delays planned resumption of international flights to late December

With the exception of flights to and from New Zealand, Australian...